Naotoshi Nakamura

This study models oseltamivir's effects on viral shedding and symptom outcomes in experimental influenza infections using clinical trial data, finding no significant antiviral efficacy or dose-dependent effects.

This study stratifies SARS-CoV-2 viral shedding patterns in saliva into three groups with distinct durations using a mathematical model and clustering, but finds no clear clinical or miRNA biomarkers explaining the differences.

The paper analyzes longitudinal antibody titers post-vaccination to identify individuals at risk for breakthrough infections and identifies three population groups with distinct immune response patterns.